IndraLab

Statements



reach
"These results indicate that USP9X is a critical antagonist of PCP activation and cell motility in MDA-MB-231 cells and that this function is dependent on the ubiquitylation of DVL2."

reach
"Importantly, depletion of USP9X in MDAMB231 metastatic breast cancer cells, which have elevated SMURF1 expression, inhibits SMURF1 dependent breast cancer cell motility [XREF_BIBR]."